CFDE Data Portal | Search LINC02985

	Label	Description
	LINC02985 Gene (Entity type)	ENSG00000256546 - long intergenic non-protein coding RNA 2985
	GSE173116 GSE173118 ML-7 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE169617 azacitidine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE133933 fibulin-3 knockdown 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE104526 p53 LSD1 inhibition 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 9 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE217085 L-25 HeLa 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02985

ENSG00000256546 - long intergenic non-protein coding RNA 2985

GSE173116 GSE173118 ML-7 3 v 5 human up

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 7 human up

A Gene Set from LINCS

GSE169617 azacitidine 1 v 2 human up

A Gene Set from LINCS

GSE108464 AZ-628 1 v 2 human dn

A Gene Set from LINCS

GSE133933 fibulin-3 knockdown 0 v 3 human up

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 0 v 5 human dn

A Gene Set from LINCS

GSE104526 p53 LSD1 inhibition 1 v 0 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 9 v 1 human dn

A Gene Set from LINCS

GSE217085 L-25 HeLa 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.